[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@medtechmd Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::329402736.png) @medtechmd Will

Will posts on X about $tmdx, countries, $4543t, $xyl the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::329402736/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:interactions.svg)

- X Week XXXXX +152%
- X Month XXXXXX +30%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +221%

### Mentions: X [#](/creator/twitter::329402736/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:posts_active.svg)

- X Week XX +14%
- X Month XX +65%
- X Months XXX +1.20%
- X Year XXX +107%

### Followers: XXX [#](/creator/twitter::329402736/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:followers.svg)

- X Week XXX +0.13%
- X Month XXX +1.50%
- X Months XXX +11%
- X Year XXX +34%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::329402736/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::329402736/influence)
---

**Social category influence**
[countries](/list/countries)  XXXX% [stocks](/list/stocks)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$tmdx](/topic/$tmdx) #50, [countries](/topic/countries) 2.04%, [$4543t](/topic/$4543t) #15, [$xyl](/topic/$xyl) #6, [mexico](/topic/mexico) 2.04%, [$kura](/topic/$kura) 2.04%, [$edap](/topic/$edap) 1.02%, [jersey](/topic/jersey) 1.02%, [focal](/topic/focal) 1.02%, [$lnth](/topic/$lnth) XXXX%

**Top accounts mentioned or mentioned by**
[@focalonehifu](/creator/undefined) [@billackman](/creator/undefined) [@clevelandclinic](/creator/undefined) [@ccad](/creator/undefined) [@aldcabreu](/creator/undefined) [@brunonahar](/creator/undefined) [@londonprostate1](/creator/undefined) [@tanejauro](/creator/undefined) [@nyuurology](/creator/undefined) [@focalsociety](/creator/undefined) [@robmtaub](/creator/undefined) [@scaramucci](/creator/undefined) [@medpagetoday](/creator/undefined) [@dytcmd](/creator/undefined) [@rdroncadrs](/creator/undefined) [@revshark](/creator/undefined)

**Top assets mentioned**
[TransMedics Group, Inc. Common Stock (TMDX)](/topic/$tmdx) [Xylem Inc (XYL)](/topic/$xyl) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [GE HealthCare Technologies Inc. Common Stock (GEHC)](/topic/ge-healthcare) [Huma Finance (HUMA)](/topic/$huma) [Frontline Ltd. (FRO)](/topic/$fro)
### Top Social Posts [#](/creator/twitter::329402736/posts)
---
Top posts by engagements in the last XX hours

"MD Anderson at Cooper Now Offering New Non-Invasive High-Intensity Focused Ultrasound Procedure for Prostate Cancer. NJ Health Systems Utilizing $EDAP Focal One HIFU: Hackensack Meridian Morristown St. Josephs Hackensack Jersey Shore Cooper Univ"  
[X Link](https://x.com/medtechmd/status/1976077130854228194) [@medtechmd](/creator/x/medtechmd) 2025-10-09T00:07Z XXX followers, XXX engagements


"$LNTH and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan"  
[X Link](https://x.com/medtechmd/status/1970792304244863178) [@medtechmd](/creator/x/medtechmd) 2025-09-24T10:07Z XXX followers, XXX engagements


"Parkinson's breakthrough: British-led gene therapy hailed as 'game changer' for millions Dr Ali Rezai a neuroscientist and Director of the US Rockefeller Neuroscience Institute West Virginia said: These safety and outcome results are excellent. $MGTX"  
[X Link](https://x.com/medtechmd/status/1977539935222513758) [@medtechmd](/creator/x/medtechmd) 2025-10-13T01:00Z XXX followers, 3762 engagements


"$TMDX CEO Hassanein MS Conference: Because of the success of NOP we are getting a lot of interest from OUS countries to replicate the program in their country. XX% of the transplants in the US are DCD. TMDX pioneered this initiative. The competition from Terumo keeps us honest"  
[X Link](https://x.com/medtechmd/status/1965058659005988921) [@medtechmd](/creator/x/medtechmd) 2025-09-08T14:24Z XXX followers, 3294 engagements


"$TMDX outcomes in liver transplant are much better than OrganOx/Terumo. Thats why they are cheaper"  
[X Link](https://x.com/medtechmd/status/1965060272500187614) [@medtechmd](/creator/x/medtechmd) 2025-09-08T14:30Z XXX followers, XXX engagements


"$XYL and Amazon Partner on Smart Water Upgrades to Save More Than XXX Billion Liters Annually in Mexico -"  
[X Link](https://x.com/medtechmd/status/1966148702357372930) [@medtechmd](/creator/x/medtechmd) 2025-09-11T14:35Z XXX followers, XXX engagements


"Water conservation treatment and sustainability becoming more mainstream. $XYL the pure play innovator in the water space"  
[X Link](https://x.com/medtechmd/status/1966150272834744707) [@medtechmd](/creator/x/medtechmd) 2025-09-11T14:42Z XXX followers, XXX engagements


"$HUMA Price Target $XXXX. The Board of Directors Needs To Lookout For the Interests of Shareholders and Change Company Management"  
[X Link](https://x.com/medtechmd/status/1977697750251622863) [@medtechmd](/creator/x/medtechmd) 2025-10-13T11:27Z XXX followers, 1878 engagements


"Jefferies comments on $KURA Komet-007 trial. This trial expands zifto's footprint into frontline settings complementing ongoing KOMET-017 registrational study"  
[X Link](https://x.com/medtechmd/status/1974894973582766386) [@medtechmd](/creator/x/medtechmd) 2025-10-05T17:50Z XXX followers, 3036 engagements


"Final Trial Data Show Success for $KURA Ziftomenib in NPM1 AML: ziftomenib was well tolerated with manageable differentiation syndrome lack of clinically significant QTc prolongation and low rates of myelosuppression"  
[X Link](https://x.com/medtechmd/status/1975306503679627356) [@medtechmd](/creator/x/medtechmd) 2025-10-06T21:05Z XXX followers, XXX engagements